199 related articles for article (PubMed ID: 20824100)
1. Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.
Cavet ME; Harrington KL; Ward KW; Zhang JZ
Mol Vis; 2010 Sep; 16():1791-800. PubMed ID: 20824100
[TBL] [Abstract][Full Text] [Related]
2. BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.
Zhang JZ; Cavet ME; VanderMeid KR; Salvador-Silva M; López FJ; Ward KW
Mol Vis; 2009 Dec; 15():2606-16. PubMed ID: 20011631
[TBL] [Abstract][Full Text] [Related]
3. Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells.
Spinelli SL; Xi X; McMillan DH; Woeller CF; Richardson ME; Cavet ME; Zhang JZ; Feldon SE; Phipps RP
Exp Eye Res; 2014 Oct; 127():290-8. PubMed ID: 25245083
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells.
Cavet ME; Harrington KL; Vollmer TR; Ward KW; Zhang JZ
Mol Vis; 2011 Feb; 17():533-42. PubMed ID: 21364905
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
[TBL] [Abstract][Full Text] [Related]
6. Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.
Cavet ME; Volhejn S; Harrington KL; Zhang JZ
Mol Vis; 2013; 19():1515-25. PubMed ID: 23878502
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1).
Vollmer TR; Stockhausen A; Zhang JZ
J Biol Chem; 2012 Oct; 287(42):35212-35221. PubMed ID: 22898817
[TBL] [Abstract][Full Text] [Related]
8. Mapracorat, a novel non-steroidal selective glucocorticoid receptor agonist for the treatment of allergic conjunctivitis.
Baiula M; Spampinato S
Inflamm Allergy Drug Targets; 2014; 13(5):289-98. PubMed ID: 25373600
[TBL] [Abstract][Full Text] [Related]
9. 17-β-estradiol inhibits hyperosmolarity-induced proinflammatory cytokine elevation via the p38 MAPK pathway in human corneal epithelial cells.
Wang C; Shi X; Chen X; Wu H; Zhang H; Xie J; Yang X; Gou Z; Ye J
Mol Vis; 2012; 18():1115-22. PubMed ID: 22605923
[TBL] [Abstract][Full Text] [Related]
10. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.
Baiula M; Bedini A; Baldi J; Cavet ME; Govoni P; Spampinato S
Drug Des Devel Ther; 2014; 8():745-57. PubMed ID: 24959069
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells.
Zhang JZ; Cavet ME; Ward KW
Curr Eye Res; 2008 Nov; 33(11):923-32. PubMed ID: 19085374
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
Seo MJ; Kim JM; Lee MJ; Sohn YS; Kang KK; Yoo M
Curr Eye Res; 2010 Feb; 35(2):165-75. PubMed ID: 20136427
[TBL] [Abstract][Full Text] [Related]
13. In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease.
Shafiee A; Bucolo C; Budzynski E; Ward KW; López FJ
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1422-30. PubMed ID: 20881303
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells.
Li DQ; Chen Z; Song XJ; Luo L; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4302-11. PubMed ID: 15557436
[TBL] [Abstract][Full Text] [Related]
15. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface.
Luo L; Li DQ; Corrales RM; Pflugfelder SC
Eye Contact Lens; 2005 Sep; 31(5):186-93. PubMed ID: 16163009
[TBL] [Abstract][Full Text] [Related]
16. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells.
Li DQ; Luo L; Chen Z; Kim HS; Song XJ; Pflugfelder SC
Exp Eye Res; 2006 Apr; 82(4):588-96. PubMed ID: 16202406
[TBL] [Abstract][Full Text] [Related]
17. Ocular pharmacokinetics of mapracorat, a novel, selective glucocorticoid receptor agonist, in rabbits and monkeys.
Proksch JW; Lowe ER; Ward KW
Drug Metab Dispos; 2011 Jul; 39(7):1181-7. PubMed ID: 21441467
[TBL] [Abstract][Full Text] [Related]
18. NF-κB feedback control of JNK1 activation modulates TRPV1-induced increases in IL-6 and IL-8 release by human corneal epithelial cells.
Wang Z; Yang Y; Yang H; Capó-Aponte JE; Tachado SD; Wolosin JM; Reinach PS
Mol Vis; 2011; 17():3137-46. PubMed ID: 22171160
[TBL] [Abstract][Full Text] [Related]
19. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways.
Chen M; Hu DN; Pan Z; Lu CW; Xue CY; Aass I
Exp Eye Res; 2010 Mar; 90(3):437-43. PubMed ID: 20026325
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors.
Ma W; Gee K; Lim W; Chambers K; Angel JB; Kozlowski M; Kumar A
J Immunol; 2004 Jan; 172(1):318-30. PubMed ID: 14688340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
